AJP - Heart Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 289: H908-H915, 2005. First published April 1, 2005; doi:10.1152/ajpheart.00781.2004
0363-6135/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/2/H908    most recent
00781.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (17)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chacko, B. K.
Right arrow Articles by Patel, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chacko, B. K.
Right arrow Articles by Patel, R. P.

Revealing anti-inflammatory mechanisms of soy isoflavones by flow: modulation of leukocyte-endothelial cell interactions

Balu K. Chacko,1 Robert T. Chandler,1 Ameya Mundhekar,1 Nicholas Khoo,3 Heather M. Pruitt,1 Dennis F. Kucik,1,6 Dale A. Parks,3,5 Christopher G. Kevil,7 Stephen Barnes,2,4 and Rakesh P. Patel1,4,5

Departments of 1Pathology, 2Pharmacology, and 3Anesthesiology, 4Purdue-University of Alabama at Birmingham Botanical Center for Age-Related Disease, and 5Center for Free Radical Biology, University of Alabama at Birmingham; and 6Research Service, Birmingham Veterans Affairs Medical Center, Birmingham, Alabama; and 7Department of Pathology, Louisiana State University, Shreveport, Louisiana

Submitted 2 August 2004 ; accepted in final form 28 March 2005

The antiatherogenic effects of soy isoflavone consumption have been demonstrated in a variety of studies. However, the mechanisms involved remain poorly defined. Adhesion of monocytes to vascular endothelial cells is a key step within the inflammatory cascade that leads to atherogenesis. Many factors, including the physical forces associated with blood flow, regulate this process. Using an in vitro flow assay, we report that genistein, a principal component of most isoflavone preparations, inhibits monocyte adhesion to cytokine (TNF-{alpha})-stimulated human vascular endothelial cells at physiologically relevant concentrations (0–1 µM). This effect is absolutely dependent on flow and is not observed under static conditions. Furthermore, this inhibition was dependent on activation of endothelial peroxisomal proliferator-activated receptor-{gamma}. No significant role for other reported properties of genistein, including antioxidant effects, inhibition of tyrosine kinases, or activation of estrogen receptors, was observed. Furthermore, the antiadhesive effects of genistein did not occur via modulation of the adhesion molecules E-selectin, ICAM-1, VCAM-1, or platelet-endothelial cell adhesion molecule-1. These data reveal a novel anti-inflammatory mechanism for isoflavones and identify the physical forces associated with blood flow and a critical mediator of this function.

inflammation; genistein; peroxisomal proliferator-activated receptor-{gamma}; atherosclerosis; monocytes



Address for reprint requests and other correspondence: R. P. Patel, Dept. of Pathology, Univ. of Alabama at Birmingham, 901 19th St. South, BMR-2, Rm. 307, Birmingham, AL 35294 (E-mail: patel{at}path.uab.edu)




This article has been cited by other articles:


Home page
J. Nutr.Home page
S. Nagarajan, R. L. Burris, B. W. Stewart, J. E. Wilkerson, and T. M. Badger
Dietary Soy Protein Isolate Ameliorates Atherosclerotic Lesions in Apolipoprotein E-Deficient Mice Potentially by Inhibiting Monocyte Chemoattractant Protein-1 Expression
J. Nutr., February 1, 2008; 138(2): 332 - 337.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
B. K. Chacko, R. T. Chandler, T. L. D'Alessandro, A. Mundhekar, N. K. H. Khoo, N. Botting, S. Barnes, and R. P. Patel
Anti-Inflammatory Effects of Isoflavones are Dependent on Flow and Human Endothelial Cell PPAR{gamma}
J. Nutr., February 1, 2007; 137(2): 351 - 356.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. Nagarajan, B. W. Stewart, and T. M. Badger
Soy Isoflavones Attenuate Human Monocyte Adhesion to Endothelial Cell-Specific CD54 by Inhibiting Monocyte CD11a
J. Nutr., September 1, 2006; 136(9): 2384 - 2390.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
P. Fanti, R. Asmis, T. J. Stephenson, B. P. Sawaya, and A. A. Franke
Positive effect of dietary soy in ESRD patients with systemic inflammation--correlation between blood levels of the soy isoflavones and the acute-phase reactants
Nephrol. Dial. Transplant., August 1, 2006; 21(8): 2239 - 2246.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.